Trials / Completed
CompletedNCT03689673
Study of the Effectiveness of ETIASA® (Sustained Release 5-Aminosalicylate) in Maintenance Treatment of Ulcerative Colitis (UC)
A Prospective, Multicenter, Non-interventional Study to Describe the Effectiveness of Etiasa® (Sustained Release Granules of Mesalazine or 5-Aminosalicylate, or 5-ASA) in Maintenance Treatment of Ulcerative Colitis (UC )
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 607 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the protocol is to assess the effectiveness of Etiasa® for preventing relapse in Chinese patients with quiescent UC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Data collection |
Timeline
- Start date
- 2013-04-24
- Primary completion
- 2020-11-16
- Completion
- 2020-11-16
- First posted
- 2018-09-28
- Last updated
- 2021-02-02
Locations
26 sites across 1 country: China
Source: ClinicalTrials.gov record NCT03689673. Inclusion in this directory is not an endorsement.